Immucell Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,007.20
7,596.90
10,228.70
9,544.00
10,431.10
10,986.30
Cost of Goods Sold (COGS) incl. D&A
2,946.60
3,147.80
3,977.80
4,123.30
5,209.70
5,792.40
Gross Income
3,060.60
4,449.00
6,250.90
5,420.70
5,221.40
5,193.90
SG&A Expense
3,080.20
4,655.40
4,128.60
4,530.50
5,464.20
7,340.50
EBIT
19.60
206.40
-
890.20
242.80
2,146.60
Non Operating Income/Expense
281.90
3.90
5.60
24.90
6.00
700
Interest Expense
69.60
60.70
83.60
161.70
218.60
427.80
Pretax Income
205.30
255.50
2,063.50
758.30
438.50
1,860.10
Income Tax
87.90
88.30
850.30
249.90
270.30
461.60
Consolidated Net Income
117.40
167.20
1,213.20
508.40
168.10
2,321.70
Net Income
117.40
167.20
1,213.20
508.40
168.10
2,321.70
Net Income After Extraordinaries
117.40
167.20
1,213.20
508.40
168.10
2,321.70
Net Income Available to Common
117.40
167.20
1,213.20
508.40
168.10
2,321.70
EPS (Basic)
0.04
0.06
0.38
0.12
0.03
0.42
Basic Shares Outstanding
3,019.40
3,027.00
3,042.40
4,225.80
4,949.20
5,486.20
EPS (Diluted)
0.04
0.06
0.38
0.12
0.03
0.42
Diluted Shares Outstanding
3,085.00
3,027.00
3,165.70
4,336.20
4,949.20
5,486.20
EBITDA
397.70
239.70
2,648.20
1,692.60
661.60
625.90
Non-Operating Interest Income
12.50
15.60
19.20
54.70
16.90
14.30
About Immucell
View Profile
